UNIVERSITY OF HULL

Short acting beta agonist inhalers (aka 'blue inhalers') are often used to relieve symptoms in asthma. Frequent blue inhaler use can reflect poor asthma control and risk of asthma attacks. The Sentinel Project aims to reduce the number of blue inhalers needed by asthma patients by improving people's asthma control. Blue metered dose inhalers also have a greater impact on the environment than other inhaler types. Improving peoples' asthma control using guideline recommended treatments can also be good for the environment.

Also known as: Sentinel Project

Primary location: United Kingdom